In contrast to the control group, the COVID-19 T2DM groups exhibited a significant increase in PAR-1, NT-proBNP, HbA1c, IL-6, D-dimer, TNF-α, CRP, and homocysteine (Figure 1). This evidence concerns the gene NPPB and type 2 diabetes mellitus.